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ABSTRACT
Tensor factorization models oer an eective approach to convert
massive electronic health records intomeaningful clinical concepts
(phenotypes) for data analysis. ese models need a large amount
of diverse samples to avoid population bias. An open challenge
is how to derive phenotypes jointly across multiple hospitals, in
which direct patient-level data sharing is not possible (e.g., due to
institutional policies). In this paper, we developed a novel solution
to enable federated tensor factorization for computational pheno-
typing without sharing patient-level data. We developed secure
data harmonization and federated computation procedures based
on alternating directionmethod of multipliers (ADMM). Using this
method, themultiple hospitals iteratively update tensors and trans-
fer secure summarized information to a central server, and the
server aggregates the information to generate phenotypes. We
demonstrated with real medical datasets that our method resem-
bles the centralized training model (based on combined datasets)
in terms of accuracy and phenotypes discovery while respecting
privacy.
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1 INTRODUCTION
Electronic health records (EHRs) become one of most important
sources of information about patients, which provide insight into
diagnoses [19] and prognoses [11], as well as assist in the develop-
ment of cost-eective treatment andmanagement programs [1, 12].
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But meaningful use of EHRs is also accompanied with many chal-
lenges, for example, diversity of populations, heterogeneous of in-
formation, and data sparseness. e large degree of missing and
erroneous records also complicates the interpretation and analy-
sis of EHRs. Furthermore, clinical scientists are not used to the
complex and high-dimensional EHR data [8, 21]. Instead, they are
more accustomed to reasoning based on accurate and concise clini-
cal concepts (or phenotypes) such as diseases and disease subtypes.
Useful phenotypes should capture multiple aspects of the patients
(e.g., diagnosis, medication and lab results) and be both sensitive
and specic to the target patient population. Although some phe-
notypes can be easily concluded based on EHR data, a wide range
of clinically important ones such as disease subtypes are not obtain-
able in a straightforward manner. e transformation from EHR
data into useful phenotypes, or phenotyping is a fundamental chal-
lenge to learn from EHR data. Current approaches for translating
EHR data into useful phenotypes are typically slow, manually in-
tensive and limited in scope [4, 5]. Overcoming several disadvan-
tages of the previous methods, tensor factorization methods have
shown great potential in discovering meaningful phenotypes from
complicated and heterogeneous health records [13, 14, 28].
Nevertheless, phenotypes developed from one hospital are of-
ten limited due to a small sample size and inherent population bias.
Ideally, we would like to compute phenotypes on a large popula-
tion with data combined from multiple hospitals. However, this
will require healthcare data sharing and exchange, which are of-
ten impeded by policies due to the privacy concerns. For exam-
ple, PCORnet data privacy guidance does not allow record-level
research participant information sharing and it recommends amin-
imumcount threshold (e.g., 10) for aggregate data sharing [25]. e
same threshold is used in Informatics for Integrating Biology &
the Bedsides (I2B2) [24], a famous system developed by National
Center for Biomedical Computing based at Partners HealthCare.
e real-world challenges motivate the development of a federated
phenotyping method to learn phenotypes across multiple hospitals
with mitigated privacy risks.
In the federatedmethod, the hospitals performmost of computa-
tions, and a semi-trusted server supports the hospital by aggregat-
ing results from hospitals. e hospitals demand a certain form of
summarized patient information (not patient-level data) anyhow
for updating tensor. A challenge of the federated tensor factoriza-
tion is that the summarized information can disclose the patient-
level data. For example, an objective function of tensor factoriza-
tion is | |X − O||2 where X is a tensor to be estimated using an
observed tensor O. Because the objective function is not linearly
separable over hospitals, tensor factorization for each hospital in-
evitably demands the others patient-level data. us, hospitals
should share summarized information that does not disclose the
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patient-level data but instead contains accurate phenotypes from
the patient-level data.
However, sharing the summarized information raises another
challenge when the data are distributed in many hospitals as a
relatively small size, or when the data are unevenly distributed.
Because of sampling error, noise in the summarized information
can increase with small patient populations. Accuracy then can
be decreased or unstable. erefore, we need to ensure the robust-
ness of summary information even with small sized or unevenly
distributed samples.
In this paper, we develop federatedTensor factorization for privacy
preserving computationalphenotyping (Trip), a new federated frame-
work for tensor factorization over horizontally partitioned data
(i.e., data are partitioned based on rows or patients). Our major
contributions are the following:
i) Accurate and fast federated method: Trip is as accurate
as centralized training model (based on combined datasets). e
accuracy of Trip is robust on the patient size or distribution. Trip
is fast compared to the centralized training model thanks to feder-
ated computation.
ii) Rigorous privacy and security analysis: Trip preserves
the privacy of patient data by transferring summarized informa-
tion. We prove that the summarized information does not disclose
the patient data.
iii) Phenotype discovery from real datasets: Phenotypes
that Trip discovers without sharing the patient-level data are the
same phenotypes based on the combined data. Trip even discovers
some phenotypes that individual hospital cannot discover due to
biased and limited population.
2 RELATED WORKS
Many privacy preserving data mining algorithms aim at construct-
ing a global model only from aggregated statistics locally gener-
ated by participating institutions on their own data, without seeing
others’ data at a ne-grained level [22, 27]. More rigorous privacy
criteria like dierential privacy [10], which introduces noises, have
been applied for several classication models through parameter
or objective perturbations [6]. However, this is not desirable for
computational phenotyping applications because noise can lead to
“ghost” phenotypes, which do not exist in the original databases
and might mislead healthcare providers with severe consequences.
In this work, we will consider privacy protection like in the former
privacy preserving data mining methods to compute phenotypes
by only exchanging summary statistics, calculated by local partic-
ipants.
Tensor factorization emerged as a promising solution for com-
putational phenotyping thanks to its interpretability and exibility.
In themedical context, tensor factorization has been adapted to en-
force sparsity constraints [13], model interactions among groups
of the same modality [14], and absorbing prior medical knowledge
via customized regularization terms [28]. Our goal is to develop a
federated tensor factorization framework to compute phenotypes
in a privacy-preserving way. is is dierent from distributed ten-
sor factorization models [7, 16] and grid tensor factorization mod-
els [9]. e laer assumes data spread across dierent but inter-
connected computer systems, in which the communication cost is
Table 1: Notations and symbols
◦ outer product
⊙ Khatri-Rao product
R number of ranks
N number of modes (order)
K number of hospitals
A,B matrix
X,O tensor
O(n) matricized tensor of O on nth mode
negligible and data/computation can be arbitrarily reallocated to
improve parallelization eciency. In contrast, ourTrip framework
deals with data stored in separate sources (hospital at dierent lo-
cations) and requires the ability to go through policy barriers using
accepted practices that respect privacy.
3 PRELIMINARIES
We rst describe some preliminaries of tensor factorization, and
summarize the notations and symbols in Table 1.
Denition 3.1. Outer product ofN vectors a(1)◦· · ·◦a(N ) makes
N -order rank-one tensor X.
Denition 3.2. Kronecker product of two vectors a ∈ RIa×1 and
b ∈ RIb×1 is
a ⊗ b =

a1b
.
.
.
aIa b

∈ RIa Ib×1.
Denition 3.3. Kharti-Rao product of two matrices A ∈ RIA×R
and B ∈ RIB×R is A ⊙ B = [a1 ⊗ b1 · · · aR ⊗ bR ] ∈ R
IA IB×R .
Denition 3.4. Matricization is to reshape the tensor into a ma-
trix by unfolding elements of the tensor. Mode-n matricization of
tensor O is denoted as O(n).
Tensor factorization is a dimensionality reduction approach that
represents the original tensor as a lower dimensional latent matrix.
e CANDECOMP/PARAFAC (CP) [3] model is the most common
tensor factorization, which approximates the original tensor O as
X, a linear combination of R rank-one tensors that are made from
outer product of N vectors. at is, CP tensor factorization is rep-
resented as
O ≈ X =
R∑
r=1
A
(1)(:, r ) ◦ · · · ◦ A(N )(:, r ),
where A(n)(:, r ) refers to the r th column of A(n). Here, A(n) is the
nth factor matrix. R is referred as the rank of the X. e columns
from factor matrices represent latent concepts that describe the
data as lower dimensions.
Tensor factorization for phenotyping is to compute a factorized
tensor X that contains latent medical concepts from data (or ob-
served tensor O). X consists of the R most prevalent phenotypes.
e nth factor matrix, A(n) denes the elements from the mode n
to comprise the phenotypes. at is, r th phenotype consists of r th
column of factor matrices [13].
e objective function of the tensor factorization with regular-
ization terms for pairwise distinct constraints [28] is formulated
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Figure 1: Process of federated tensor factorization.
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Figure 2: Equivalence between tensor factorization with re-
spect to each local tensor Ok and tensor factorization with
respect to global tensor O. Without O, tensor factorization
that is globally optimal across hospitals can be achieved via
local tensor factorization.
as
min
X
Ψ =| |X − O||2F +
N∑
n=1
λ
2
| |I − A(n)TA(n) | |2F . (1)
It is rewrien with respect to mode-n matricization
min
A(n)
Ψ = | |A(n)Π(n)T − O(n) | |
2
F +
λ
2
| |I − A(n)TA(n) | |2F . (2)
where Π(n) = A(N ) ⊙ . . . ⊙A(n+1) ⊙A(n−1) ⊙ . . . ⊙A(1). is is our
decomposition goal in the rest of this paper. Solving the problem
(1) while preserving privacy is technically challenging because the
tensor residual termX − O inherently contains other hospitals’ pa-
tient data that involve sensitive information.
4 FEDERATED TENSOR FACTORIZATION
We rst provide a general overview of the Trip and then formulate
the problem with iterative updating rules for optimization.
4.1 Overview
Trip is a federated tensor factorization for horizontally partitioned
patient data. We assume the data are horizontally partitioned along
patient mode, that is, hospitals have their own patient data on the
same medical features (Figs. 1, 2). Let us assume that there are K
hospitals and a central server, where the server distributes most
decomposition computation to hospitals and aggregates interme-
diate results from them. We assume Honest-but-Curious adversary
model, in which the server and hospitals are curious on data of oth-
ers but do not maliciously manipulate intermediate results [18].
A local observed tensor Ok is the local patient data in hospital
k (Fig. 2); a local factorized tensor Xk is the factorized tensor gen-
erated by local observed tensor in hospital k , Xk has N modes for
the set of patient and medical features (eg. medication, diagnosis).
In this case, N = 3 because we have modes for patient, medica-
tion, and diagnosis. e horizontally partitioned patient mode of
each Xk is generated from distinct set of patients whose size is
I1k . For simplicity, rst mode (n = 1) always denotes patient mode.
On the other hand, N − 1 medical features modes that hospitals
share of each Xk is generated from the same set of N − 1 medical
features whose size is In , (n = 2, . . . ,N ). For example, diagno-
sis and medication can be the feature modes. e size of Xk is
I1k × I2 × · · · × IN , ∀k .
We assume that factor matrix on feature modes of the local fac-
torized tensor Xk is the same for all the hospitals. By assuming
that, all hospitals are enforced to share the same phenotypes. Also,
the objective function Ψ in Eq. (1) can be linearly separable on
hospitals; consequently hospitals can update their local factorized
tensor indirectly using other hospitals’ patient data while respect-
ing privacy.
e local factorized tensor Xk is computed as following steps:
rst, in patient mode, hospital k (k = 1, . . . ,K ) computes local fac-
tor matrix independently (step 1) in Fig. 1. For feature modes, hos-
pital k computes the local factor matrices (step 2) and send them
together with the Lagrangian multipliers to the server (step 3). e
server then generates harmonized factor matrix (global factor ma-
trix) by combining all the local factor matrices with Lagrangian
multipliers (step 4). Aer receiving the global factor matrix (step
5), hospitalk updates the Lagrangian multipliers (step 6). Hospitals
and the server repeat the procedures until the local factor matrices
are converged. During the procedures, the global factor matrices
can retain phenotypes from local factor matrices without directly
using the local patient data.
4.2 Formulation
Werst formulate separable objective function on hospitals for fed-
erated tensor factorization. e objective function for tensor fac-
torization, Ψ in Eq. (1) is reformulated with respect to the local
factorized tensor.
Xk is decomposed into factor matrices A
(1)
k
∈ RI1k×R (patient
mode) and A
(n)
k
∈ RIn×R ,n ≥ 2 (feature modes). We assume that
the local factor matrices of feature modes A
(n)
k
from all hospitals
are equal to the global factor matrix (Fig. 2), i.e.,
A
(n)
= A
(n)
1 = A
(n)
2 = . . . = A
(n)
K
, n ≥ 2. (3)
is assumption is reasonable because all hospitals aim to have the
same phenotypes and share themwith others. By assuming Eq. (3),
the horizontal concatenation of the local factor matrices of patient
mode A
(1)
k
forms the (global) factor matrix A(1) (Fig. 2):
A
(1)
=

A
(1)
1 ;
.
.
.
A
(1)
K

. (4)
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Accordingly, we represent the global factorized tensor X in Eq. (1)
with respect to the local factorized tensor Xk (Fig. 2) as
X =

X1;
.
.
.
XK

=

∑
r A
(1)
1 (:, r ) ◦ A
(2)(:, r ) ◦ · · · ◦ A(N )(:, r );
.
.
.∑
r A
(1)
K
(:, r ) ◦ A(2)(:, r ) ◦ · · · ◦ A(N )(:, r )

,
and we can make the objective function Ψ linearly separable on k
as | |X − O||2
F
=
∑K
k=1
| |Xk − Ok | |
2
F
. e optimization problem for
tensor factorization is reformulated with respect to local tensors:
min
Xk
Ψ =
K∑
k=1
| |Xk − Ok | |
2
F +
N∑
n=2
λ
2
| |I − B(n)TA(n) | |2F
s .t .A(n) = A
(n)
k
n ≥ 2,∀k
B
(n)
= A
(n) n ≥ 2.
(5)
Here, the non-convex second term | |I − A(n)TA(n) | |2
F
in Eq. (1) is
replaced to a convex term | |I − B(n)TA(n) | |2
F
using B(n) such that
A
(n)
= B
(n). We assume that the pairwise constraint is only ap-
plied to the feature modes. is assumption is reasonable because
phenotypes are dened as only combination of medical features in
feature modes.
Augmented Lagrangian function L for the new optimization
problem (5) is
L = Ψ+
K∑
k=1
N∑
n=2
[
(A(n) − A
(n)
k
)TH
(n)
k
+
ω
2
| |A(n) − A
(n)
k
| |2F
]
+
N∑
n=2
[
(B(n) − A(n))T Y(n) +
µ
2
| |B(n) − A(n) | |2F
]
where H
(n)
k
and Y(n) are the Lagrangian multipliers. e penalty
terms that are multiplied by parameter ω and µ help L to improve
the convergence property (i.e., method of multiplier) [23] during
federated optimization in Section 4.3.
4.3 Federated optimization
e optimization problem (5) is then solved via consensus alter-
nating direction method of multipliers (ADMM) [2], which decom-
poses the original problem into sub-problems using auxiliary vari-
ables and ensures convergence to a stationary point even with non-
convex problem [15]. Our problem is decomposed to sub-problems
for hospitals with respect to the local factor matrices. Individual
components of the local factor matrices are iteratively updated
while other local factor matrices are xed. Once all hospitals up-
date the local factor matrices, server updates the global factor ma-
trix and send it back to every hospital. Hospitals and server repeat
this procedure until the local factor matrices converge before max-
imum iteration.
4.3.1 Patient mode. Because the factor matrix for patient mode
does not need to be shared, each hospital updates the local factor
matrix without sharing the intermediate results. e local matri-
cized residual tensor on patient mode is
(Xk − Ok )(1) = A
(1)
k
Π
(1)T − O(1)k ∈ R
I1k×(I2 · · ·IN ) .
Horizontal concatenation of the local matricized residual tensors
A
(1)
k
Π
(1)T −O(1)k from K hospitals becomes the global matricized
residual tensor A(1)Π(1)T −O(1). To computeA
(1)
k
, we separate the
rst term in Ψ in Eq. (1) to each hospital as
| |A(1)Π(1)T − O(1) | |
2
F =
K∑
k=1
| |A
(1)
k
Π
(1)T − O(1)k | |
2
F . (6)
By seing derivatives of Ψ with respect to A
(1)
k
to zero, a closed
form solution for updating A
(1)
k
is
A
(1)
k
= {O(1)kΠ
(1)}{Π(1)T Π(1)}−1. (7)
4.3.2 Feature modes. Hospitals update the local factormatrices
using the global factor matrix, and server makes the global factor
matrix by aggregating the intermediate local factor matrices from
hospitals in turn.
Update the local factor matrices: e local matricized residual
tensor on feature modes is
(Xk − Ok )(n) = A
(n)
Π
(n)T
k
− O(n)k ∈ R
In×(IN · · ·In+1 In−1 · · ·I1k )
where Π
(n)
k
= A
(N )
k
⊙ . . . ⊙ A
(n+1)
k
⊙ A
(n−1)
k
⊙ . . . ⊙ A
(1)
k
, n ≥
2. Contrast to patient mode, vertical concatenation of the local
matricized residual tensors A(n)Π
(n)T
k
− O(n)k becomes the global
matricized residual tensor A(n)Π(n)T − O(n). e rst term in Ψ
becomes
| |A(n)Π(n)T − O(n) | |
2
F =
K∑
k=1
| |A
(n)
k
Π
(n)T
k
− O(n)k | |
2
F (8)
with A(n) = A
(n)
k
. e closed form solution for A
(n)
k
is
A
(n)
k
= {O(n)kΠ
(n)
k
+ ωA(n) + H
(n)
k
}{Π
(n)T
k
Π
(n)
k
+ ωI}−1. (9)
is closed form solution updates the local factor matrices using
the both local observed tensor O(n)k and global factor matrix A
(n).
at is, each hospital uses both their patient data and the common
phenotypes from others to update their local phenotypes. Now,
hospitals send the local information A
(n)
k
and H
(n)
k
to server for
following updates on the global factor matrix.
Update the global factor matrix: Server updates the global fac-
tor matrix based on the local information. e objective function
is
min
A(n)
λ
2
| |I − B(n)TA(n) | |2F +
µ
2
| |A(n) − B(n) − Y(n)/µ | |2F
+
ω
2
K∑
k=1
| |A(n) − A
(n)
k
+ H
(n)
k
/ω | |2F
that also uses the pairwise constraint. A(n) is updated to be similar
withA
(n)
k
in the third term. at is, the global phenotypes aremade
to be similar with all other hospitals’ phenotypes. By derivatives of
this function with respect to A(n), we derive the following closed
form solution:
A
(n)
={(µ + Kω)I + λB(n)B(n)T }−1
·{λB(n) + µB(n) + Y(n) + ω
∑
k
A
(n)
k
−
∑
k
H
(n)
k
}.
(10)
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Algorithm 1 Trip
1: Input: O, λ,ω, µ
2: Initialize A
(n)
k
,H
(n)
k
,Y
(n).
3: repeat
4: // Update patient mode n = 1
5: Hospitals set A
(1)
k
∀k (Eq. 7).
6: for n = 2, . . . ,N do //Update feature modes
7: Hospitals set and send A
(n)
k
∀k (Eq. 9).
8: Server sets and sends A(n) (Eq. 10).
9: Server sets B(n) and Y(n) (Eq.11, 12).
10: Hospitals set and send H
(n)
k
∀k (Eq. 13).
11: end for
12: until Converged
Now, server sends the global information A(n) to hospitals for the
next iteration. Server updates B(n) by
B
(n)
= A
(n)
+
1
µ
Y
(n)
. (11)
UpdateLagrangianmultipliers: Finally, server updates Lagrangian
multipliers as
Y
(n)
= Y
(n)
+ µ(B(n) − A(n)). (12)
Hospitals also updates local Lagrangian multipliers as
H
(n)
k
= H
(n)
k
+ ω(A(n) − A
(n)
k
) (13)
to adjust the gap between local and global factor matrices. e
entire procedures of updating the tensors are summarized in Algo-
rithm 1.
4.4 Convergence proof
Weprove that our federated tensor factorization (5) converges. Due
to limited space, detailed proof of inequality (17) and (22) can be
found in our technical report [17] or [2]. For each n = 2, · · · ,N ,
let us denote
x = [A
(n)
1 (:), . . . ,A
(n)
K
(:)] ∈ RInR×K ,
z = [A(n)(:), . . . ,A(n)(:)] ∈ RInR×K ,
y = [H
(n)
1 (:), . . . ,H
(n)
K
(:)] ∈ RInR×K , and
r t = xt − zt ,
(14)
for vectorized local factormatrices, global factormatrix, Lagrangian
multipliers, and residual at iteration t , respectively. en L is
rewrien as
L(x, z,y) = f (x) + д(z) + yT (x − z) + (ω/2)| |x − z | |2 (15)
where f (x) =
∑K
k=1
| |A
(n)
k
Π
(n)T
k
− O(n)k | |
2 and д(z) = λ2 | |I −
B
(n)T
A
(n) | |2+(B(n)−A(n))T Y(n)+
µ
2 | |B
(n)−A(n) | |2. Let (x∗, z∗,y∗)
be a saddle point, and dene
V t = (1/ω)| |yt − y∗ | |2 + ω | |zt − z∗ | |2. (16)
V t decreases in each iteration (proof in [17]) because
V t+1 ≤ V t − ω | |r t+1 | |2 − ω | |zt+1 − zt | |2. (17)
Adding the inequality (17) through t = 0 to∞ gives
ω
∞∑
t=0
(
| |r t+1 | |2 + | |zt+1 − zt | |2
)
≤ V 0, (18)
which implies r t → 0 and zt → zt+1 as t →∞.
Now, we dene pt = f (xt ) + д(zt ) and show pt converges. Be-
cause (x∗, z∗,y∗) is a saddle point,
L(x∗,z∗,y∗) ≤ L(xt+1 ,zt+1,y∗). (19)
at is, using x∗ = z∗ at the saddle point,
p∗ ≤ pt+1 + y∗T r t+1 + (ω/2)| |r t+1 | |2, (20)
which implies that upper bound of p∗ − pt+1 is
p∗ − pt+1 ≤ y∗T r t+1 . (21)
Lower bound of p∗ − pt+1 (proof in [17]) is
p∗ −pt+1 ≥ (yt+1)T r t+1 +ω(zt+1 −zt )T (r t+1 + (zt+1 −z∗)). (22)
e upper and lower bounds go to zero because r t → 0 and zt →
zt+1 as t → ∞, i.e., limt→∞ p
t
= p∗. us, the objective function
Ψ of our federated optimization converges.
4.5 Privacy analysis
In our Honest-but-Curious adversary scenario, privacy of patient
data is preserved because patient-level data are not disclosed to the
both server and hospitals. e server and hospitals cannot access
to unintended ne-grained local information. e local data are
only accessible to the corresponding hospital. e server also can-
not indirectly learn patient data from the local factor matrices. Af-
ter receiving A
(n)
k
, the server might try to do reverse-engineering
through Eq. (9). However, server cannot access to Π
(n)
k
because
A
(1)
k
from patient mode is not shared. If server accesses to Π
(n)
k
by
any chance as A
(1)
k
is leaked, reverse-engineering cannot still re-
store patient-level data. at is, the matricized unknown observed
tensor (patient data) has an equation in form ofA
(n)
k
= O(n)kΠk af-
ter removing all the known values in Eq. (9) for simplicity. e size
of the unknown information inO(n)k is In×(I1k · · · In−1In+1 · · · IN ),
and the size ofΠ
(n)
k
andA
(n)
k
is (I1k · · · In−1In+1 · · · IN )×r and In×r ,
respectively. Element-wise computation generates only In ·r equa-
tions for the unknown I1 · · · IN values. Server cannot recover the
unknown values from the In ·r equations that is less than the num-
ber of unknown values (r is always selected as In · r ≪ I1 · · · IN ).
Hospitals also cannot learn other hospitals’ data from the global
factor matrix. If hospital k ′ knows all the information of Eq. (10)
for global factor matrix by any chance, hospital k ′ cannot restore
other hospitals’ local factor matrix A
(n)
k
. If the hospital k ′ can ac-
cess to A
(n)
k
by any chance, A
(n)
k
has still insucient information
to recover the data as shown in the case of server.
4.6 Secure alignment of feature modes
In Section 4.2, we rst assume that hospitals have the same element
set for each feature in feature modes, but in practice, hospitals may
have dierent elements. For example, Hospital 1 and Hospital 2
have set of diagnosis: Y1 and Y2 (Fig. 3), but each index of Y1 and
Y2 refers to a dierent element. In this case, before concatenating
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Figure 3: Example of secure alignment on feature mode.
the local tensors, the index of feature modes should refer to the
same element among hospitals. us, we introduce a secure align-
ment method for feature modes by which hospitals do not reveal
the elements they have and get an integrated and sorted view on
the elements of feature modes. is secure alignment enables hos-
pitals to have only the position of its elements without knowing
other hospitals’ elements as like Y1 and Y2 are aligned to make the
index from two sets refer to the same element (Fig. 3). For each fea-
ture mode, hospital k assigns integer values to the set of elements
Yk (eg. ICD9 codes). Hospitals use polynomial properties of set
intersection [18]:
Lemma 4.1. A polynomial function of y that represents set of ele-
mentsYk = {yik }
I
i=1 at hospitalk is fk (y) = (y−y1k )(y−y2k ) · · · (y−
yIk ) =
∑I
i=0 aiy
i
. A yik is an element of Yk (yik ∈ Yk ) if and only
if fk (yik ) = 0.
Lemma 4.2. A polynomial function that represents intersection of
Yk and Yk′ (Yk ∩ Yk′ ) is fk ∗ r + fk′ ∗ s where r , s are polynomial
functions with дcd(r , s) = 1. Given fk ∗ r + fk′ ∗ s , one cannot learn
individual elements on Y1 and Y2 other than elements in Y1 ∩ Y2.
Hospitals express Yk as a polynomial function (or in short poly-
nomial) fk by Lemma 4.1. To prevent the factorization of the poly-
nomial, hospitalk multiplies a term r = (y−α) to fk (=fk ∗r ), where
α is a random prime number that is selected with overwhelming
probability that the α does not represent any element from Yk . For
simplicity, fk ∗ r is denoted as fk . Because computing the poly-
nomials with large |Yk | can cause computational overhead, hospi-
tals compute the polynomials’ modulus (denoted as %) by a ran-
dom prime number P (P > yk ) instead of the polynomial itself, i.e.,
hospitals compute fk%P =
[∑I
i=0(ai%P)y
i
]
%P by equivalence of
modulus operation and use it instead of fk .
en server receives fk%P from hospitals. To nd a pairwise
intersection between hospital k and k ′, server computes a pairwise
sum of polynomials as [fk%P + fk′%P]%P = [fk + fk′]%P , which
refers to the polynomial for intersection between hospital k and k ′.
Server repeats this procedure for every pair of k and k ′ (k ′ , k),
and send the K − 1 polynomials to each hospital. Hospital k then
checks whether its element yk ∈ Yk is in the pairwise intersection
of hospitalk and other hospital k ′, that is, if [fk (yk )+ fk′(yk )]%P =
0, then yk ∈ Yk ∩ Yk′ by Lemma 4.2.
By combining all the pairwise intersection with K − 1 hospitals,
hospital k checks whether the element yk is in the intersection of
all the K hospitals. For example, combining the pairwise intersec-
tion of f1(y1)+ f2(y1) = 0 (i.e., y1 ∈ Y1∩Y2) and f1(y1)+ f3(y1) , 0
(i.e., y1 < Y1 ∩ Y3) gives y1 ∈ Y1 ∩ Y2 ∩ Y
c
3 . Aer obtaining 2
K−1
intersections with Yk , hospital k sends the size of 2
K−1 intersec-
tions to server. Server collects the size of intersection from all the
K hospitals and obtain the size of all the 2K − 1 combinations of
intersections (the number of combinations is two cases, whether
in or out, for every Yk except one case when Y
c
1 ∩ . . .∩Y
c
K
). Finally,
hospitals receive the size of 2K − 1 intersection, and align their ele-
ments according to the size information. Hospitals have the same
order of these intersections such as Y1 ∩ Y2,Y1 ∩ Y
c
2 ,Y
c
1 ∩ Y2 (Fig.
3). e elements within the intersections are sorted. us, all hos-
pitals have the same size and order of elements for every feature
mode.
5 EXPERIMENTS
We evaluate Trip by measuring computational performance (accu-
racy and time) and deriving meaningful phenotypes. We compare
Trip with two baselines:
i) Central model: Ordinary tensor factorization method for phe-
notyping. Regardless of privacy problem that concerns data shar-
ing, this model runs on a central server where all the patient data
are combined [28].
ii) Local model: We devise an intuitive local model, by which
hospitals run the central model at their sides and send the nal
factor matrices of feature modes to server. Server averages the fac-
tor matrices and sends the averaged factor matrices back to hospi-
tals without iterative updating like Trip. Because each column in
factor matrices can represent dierent phenotypes over hospitals,
before averaging the matrices, server sorts the columns of each
hospital’s factor matrix so that all hospitals have the same pheno-
types at each column. For all feature modes n, server rst chooses
a pivot hospital kp and computes cosine similarity between every
pair of rp th and r th column from factor matrix of hospital kp and
other hospitals k as similarity = cos(A
(n)
kp
(:, rp ),A
(n)
k
(:, r )) where
∀k , kp , ∀r , rp . Server then nds the most similar combination
of rp and r for all pairs. Finding the best combination that matches
multiple items (columns) to multiple items can be solved in poly-
nomial time by Hungarian method [20]. Finally, server changes
the order of columns in A
(n)
k
according to the combination so that
each column from A
(n)
kp
and A
(n)
k
refer to the same phenotype.
5.1 Accuracy and Time
We use a large publicly available dataset MIMIC-III containing de-
identied health-related data associated with over forty thousand
patients who stayed in critical care units of the Beth Israel Dea-
coness Medical Center between 2001 and 2012 [26]. MIMIC-III in-
cludes information such as demographics, laboratory test results,
procedures, medications, caregiver notes, imaging reports, andmor-
tality. We construct a 3-order tensor with patients, laboratory test
results, and medication. e tensor value is the number of co-
occurrences of abnormal lab results and medication from the same
patient within specic time window. We generate four datasets
as seing the time window as 3 hours, 6 hours, 1 day, or 7 days,
and have the number of nonzero values of around 15 million (M),
25M, 40M, and 50M, respectively. e size for 7-day-window ten-
sor (MIMIC-III 50M) is 38,035 patients by 3,229 medications by 304
lab results. Because duplicated co-occurrence can be counted with
large time window, we set the maximum value of count as three,
which is a median of 1-day-window tensor (MIMIC-III 40M). e
count value larger than three is truncated to three.
Federated Tensor Factorization for Computational Phenotyping KDD’17, August 2017, Halifax, Nova Scotia, Canada
number of nonzeros (millions)
15 25 40 50
R
M
SE
1.4
1.5
1.6
1.7
1.8
1.9
2
2.1
TRIP
Central model
Local model
(a) RMSE vs # nonzeros
number of nonzeros (millions)
15 25 40 50
Ti
m
e 
(se
c)
4000
6000
8000
10000
12000
14000
16000
Comupation
Communication
Alignment
(b) Time vs. # nonzeros
iterations
0 20 40 60 80 100
R
M
SE
1.3
1.35
1.4
1.45
1.5
1.55
1.6
1.65
1.7
TRIP
Central model
Local model
(c) MIMIC-III 15M
iterations
0 20 40 60 80 100
R
M
SE
1.7
1.8
1.9
2
2.1
2.2
2.3
2.4
2.5
TRIP
Central model
Local model
(d) MIMIC-III 50M
Figure 4: RMSE and total time over the number of nonzeros (Fig. 4a, 4b). e rst, second, and third stacked bars in Fig. 4b
refer to central model, Trip, and local model, respectively. RMSE of Trip, central model, and local model over iteration (Fig.
4c, 4d).
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We evaluate accuracy and time of Trip compared to two base-
line models by varying the number of nonzero values, hospitals,
and skewness (for unevenly distributed patients). We measure ac-
curacy using root mean square error (RMSE) between the factor-
ized tensor and the observed tensor. We also measure time elapsed
by adding time for computation, communication, and alignment.
Because Trip and local model distribute computation of local ten-
sors to hospitals, we consider the computation time on the local
tensors as the largest computation time on one hospital. e com-
munication time is measured as the total number of communicated
bytes between server and hospitals divided by data transfer rate of
15 MB/sec. e communication time for central model is time for
transferring the local patient data to server. We repeat the eval-
uation ten times and average them. We run the models until it
converges before maximum iteration 100. e rank is set to ten. λ
is set to 10−2 aer trying 10−3, 10−2, 10−1, 1, and 10.
5.1.1 Number of nonzeros. We use the four MIMIC-III datasets
that have 15M, 25M, 40M, and 50M nonzero values. We assume
that MIMIC-III datasets are distributed in three hospitals, onwhich
the patients are randomly distributed as the same size. As a result,
Trip has lowRMSE asmuch as central model and resembles central
model for all the four datasets (Fig. 4a). For MIMIC-III 15M, RMSE
from central model converges to 1.4404. Similarly, the RMSE from
Trip starts to stable at around 50 iterations and converges to 1.4409
(Fig. 4c). Both of the RMSE from central model and Trip are signif-
icantly smaller than that of local model (1.5957). MIMIC-III 50M
dataset also shows similar convergence. RMSE from Trip starts
to stable at around 60 iterations and converges to 1.8482, which is
also similar to RMSE from central model, 1.8479 (Fig. 4d). MIMIC-
III 25M shows the RMSE of 1.4955 from Trip, 1.4947 from central
model, 1.6867 from local model. MIMIC-III 40M shows the RMSE
of 1.7913 from Trip, 1.7903 from central model, 2.0037 from local
model. Convergence results on MIMIC-III 25M and 40M can be
found in our technical report [17].
In addition, total time elapsed forTrip (and localmodel) is much
faster (half less) than central model in all datasets (Fig. 4b). Trip re-
duces computation time by distributing updating procedures to de-
centralized hospitals; consequently, Trip reduces total time elapsed
although sacricing communication and alignment time. For the
datasets of 15M, 25M, 40M, and 50M, computation time from Trip
is 3,152, 4,183, 5,796, and 7,125 seconds, and computation time from
central model is 5,266, 8,068, 11,661, and 15,105 seconds, which
take majority of total time. Communication time from Trip is
around 100.7 seconds for all the cases, and communication time
from central model is 30.1, 53.9, 85.0, and 114.4 seconds. Note
that Trip saves not only computation time but also communica-
tion time with large dataset (MIMIC-III 50M). Alignment time for
Trip takes 22.6, 26.1, 29.3, and 59.0 seconds, which is negligible
compared to computation time. Based on those observations, we
can see that Trip eciently resembles central model without no
KDD’17, August 2017, Halifax, Nova Scotia, Canada Y. Kim et al.
cost for privacy even at reduced time owing to distributed compu-
tation.
5.1.2 Number of hospitals. Using MIMIC-III 15M dataset, we
partition the patients evenly into one to ve hospitals. RMSE with
one hospital refers to RMSE of central model. We observed that
RMSE of Trip is stable as the number of hospitals increases, and
is similar to RMSE of central model 1.4404, whereas RMSE of local
model increase (Fig. 5a) with large variance. at is, compared to
local model, in which local factorized tensors are diverged, Trip is
robust on the nely split data. It means that phenotypes from Trip
are accurate and not biased even with many small sized patient
data.
Total time of Trip and local model are signicantly faster than
that of central model. As the number of hospitals increases and the
patient data are spread more, the total time of Trip and localmodel
decrease (Fig. 5c). Specically, computation time for Trip and lo-
cal model decrease because more hospitals distribute the computa-
tion, and communication time for Trip slightly increases, whereas
communication time for localmodel is negligibly short. Alignment
time is negligible for both Trip and local model.
5.1.3 Skewness. We partition the patients in MIMIC-III 15M
unevenly in three hospitals. One hospital takes 1/3 (evenly dis-
tributed), 0.5, 0.7, and 0.9 of patients, and the other two hospitals
take the remaining patients evenly. Note that elements in feature
mode are still overlapped enough among hospitals. We observed
that RMSE of Trip is stable although patients are distributed un-
evenly, whereas RMSE of local model is higher than that of Trip
with large variance. Factorized tensor of local model can be inaccu-
rate because the local factorized tensor from a small sized hospital
can be biased and far dierent from others’ results. However, the
hospital can benet from Trip by overcoming this bias and produc-
ing a generalized results.
Total time of Trip and localmodel increase (Fig. 5d) as the skew-
ness increases. Time for computation increases because computa-
tional overhead occurs on one hospital with large data, and time
for communication and alignment does not increase signicantly.
5.2 Phenotype discovery
We use de-identied EHRs dataset from University of California,
San Diego (UCSD) Medical Center with 8,022 patients by 748 med-
ications by 299 diagnoses. Specically, it is from two hospitals
that have 4,703 patients (UCSD1) and 3,319 patients (UCSD2). We
construct a 3-order tensor with patient, medication, and diagnosis
mode with around 1.6 million of non-zero elements. e value of
tensor is the number of co-occurrences of medication and diagno-
sis event from the same patient at the same visit.
We discover phenotypes from Trip and compare themwith phe-
notypes from central model and individual central model of two
hospitals in UCSD (i.e., run central model independently at UCSD1
and UCSD2). λ is set 1 to derive more distinct phenotypes than
those fromMIMIC-III. A domain expert summarizes the factorized
tensor into clinically meaningful phenotypes. e phenotypes con-
sist of set of diagnoses and its corresponding medications. Due to
limited space, medication factors in phenotypes are omied and
can be found in our project website [17].
As a result, Trip discovers unbiased and hidden phenotypes
compared to the phenotypes from two individual central models
(UCSD1, UCSD2). e phenotypes from Trip contain top-ranked
phenotypes from UCSD1 and UCSD2, and are similar to pheno-
types from combined central model, UCSD1+UCSD2 (Table 2). e
phenotypes from Trip consist of top ve phenotypes from UCSD1
and top four from UCSD2. e phenotypes from Trip are also the
same with phenotypes from central model except gastrointestinal
complaints and neurogenic bladder. Without our federated model,
the two individual hospitals could derive biased phenotypes that
are only ed to the local data. It means that Trip can eectively
resemble central model without cost for privacy.
In addition, Trip discovers a new phenotype, sickle cell/chronic
pain crisis, that is contained in neither of UCSD1 and UCSD2. is
phenotype consists of diagnoses related to sickle cell diseases or
chronic pain crisis and corresponding medications (Table 3). Based
on physician’s judgement, this phenotype is clinically meaningful
in that sickle cell disease usually accompanies chronic pain such as
constipation, back/neck pain, headache, (pruritic disorder, insom-
nia, and wheezing. sickle cell/chronic pain crisis is not dominant
in individual hospital but is dominant in overall perspective. Note
that RMSE of Trip is low as much as RMSE of central model while
reducing total time (Table 4), and RMSEs of two individual UCSD
datasets are lower than others because those two use separated
small local datasets. Also, note that communication time of the
central model is due to transferring the data.
6 CONCLUSIONS
is paper presents Trip, a federated tensor factorization for com-
putational phenotyping without sharing patient-level data. We de-
veloped secure data harmonization and privacy-preserving com-
putation procedures based on ADMM, and analyzed that Trip en-
sure the condentiality of patient-level data. Experimental results
on data from MIMIC-III and UCSD medical center demonstrated
that our framework resembles the central model very well. Trip
is also accurate even with small or skewly distributed patient data,
and fast compared to the central model. We also showed that Trip
discovers phenotypes as the central model with combined patient
data does, which are unbiased or not discovered (hidden) pheno-
types from each hospital. As a result, Trip can help derive useful
phenotypes from EHR data to overcome policy barriers due to the
privacy concerns. We plan to apply it to much larger scale datasets
in the future and facilitate the discovery of novel and important
“phenotypes” to support clinical research and precision medicine.
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